$21.63
Price
$2.4B
Market Cap
—
P/E Ratio
-15.7
Forward P/E
$-1.41
EPS (TTM)
—
Dividend Yield
$251M
Cash
$6M
Total Debt
111M
Shares Out
$7.63
$24.60
52-Week Range
Institutional Ownership of Amylyx Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Amylyx Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2019-Q1 | |||||
| SELL | EXIT | — | — | — | |
| 2018-Q4 | |||||
| SELL | -10.6% | 3.0M | $59M | — | |
| 2018-Q3 | |||||
| SELL | -3.2% | 3.4M | $69M | — | |
| 2018-Q2 | |||||
| SELL | -9.7% | 3.5M | $70M | — | |
| 2018-Q1 | |||||
| BUY | +8.2% | 3.8M | $75M | — | |
Insider Trading for Amylyx Pharmaceuticals Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.